350 rub
Journal Technologies of Living Systems №1 for 2011 г.
Article in number:
EVALUATION QUALITY OF LIFE IN PATIENTS WITH INVASIVE BLADDER CANCER AFTER SURGICAL THERAPY AND CHEMORADIATION
Authors:
A.D. Kaprin, N.Yu. Dobrovolskaya, A.V. Shestakov, A.D. Tsybulsky
Abstract:
Recently, in the worldwide practice the quality of life is considered to be generally accepted and highly informative indicator of health status estimation of the whole population as well as separate social groups. It gives quantitative evaluation of the many-component characteristics of human life activities - physical, psychological and social func-tioning. This is the reason why life quality study is used for evaluation and improvement of effectiveness of medical aid to patients. Health status study is considered to be full component of examination process and appears to be valuable and interesting information for the researcher in reference to internal status of patients, as the patient carries out subjective evaluation of his health presenting a real pattern of his psychosomatic state to the doctor. Quality of life study is carried out with the help of specially worked out questionnaire intended for symptom detection, laying down functioning parameters of patients and determination of performance status. Questionnaires can be either general - in other words used with chronic/long-term illnesses - or specific - applied for certain nosologic unit (particularly with oncological diseases). Apart from the general section of the questionnaire used for dif-ferent diseases, there are specially worked out modules applied for concrete nosologic form. Such methodology is indispensable in health status evaluation of patients during the whole course of treatment because it allows to ob-jectively estimate patient-s health as well as it gives an opportunity to establish the typical variant of psychosomatic reaction of patients depending on clinical parameters of the illness. Individual monitoring can be provided both in the course treatment and rehabilitation process. A special questionnaire of functional therapy study of bladder cancer (FACT-BL) is an additional specific module and used in conference with the general questionnaire FACT-G. It consists of 12 questions on estimation of body weight loss, appetite, urinary disorder, pain and its impact on functional abilities. FACT-BL is the most applicable for examination of patients with metastatic forms. However, it doesn-t allow to evaluate the influence of different complications on emotional state, professional and social activity of patients and it is restrictedly applicable with local forms of disease. Specialists from the European organization on oncological investigation and treatment have proposed the ad-ditional section (QLQ-BLM30) in conference with the standard questionnaire EORTC QLQ-C30 for life quality esti-mation of patients with bladder cancer. It includes 3 scales: estimation of urination function, gastrointestinal tract, sexual function. There are additional questions for estimation of surgical treatment influence on life quality of pa-tients. Taking into account the fact that there are different variants of bladder cancer treatment and their combina-tions, the section of chemotherapy impact (QLQ-HDC29) and the section of radiotherapy impact on small pelvis (QLQ-PRT21) was offered. Nowadays more and more attention is paid to influence of treatment on different aspects of life quality of pa-tients. Such estimation is especially relevant for patients with oncological disease of lower urinary tract, who live long life after getting such diagnosis thanks to the success in treatment this disease. Obviously, that long-term survival value can be associated with low level of life quality and for some patients such disbalance in treatment method choice can be of extreme significance. It often occurs that patients sacrifice their survival value to life quality. Nowadays influence of life quality on decision of treatment method choice is so great that many researchers consider clinical investigations of bladder cancer incomplete without evaluation of life quality level.
Pages: 24-29
References
  1. Щепия О.П. Здоровье населения Российской Федерации: проблемы и перспективы // Вестник РАМН, 1998. С. 34 - 35.
  2. Сухонос Ю.А. Особенности популяционного исследования качества жизни: Автореф. дис... канд. мед. наук. СПб. 2003.
  3. Новик А.А. Концепция исследования качества жизни в медицине. Санкт-Петербург: ЭЛБИ. 1999. С. 6 - 78.
  4. Карякин О.Б. Органосохранная тактика при инвазивном раке мочевого пузыря: «за» и «против» // Практическая онкология. 2003. Т.4. № 4. С. 252 - 255.
  5. Stewart A.L., Hays R.D., Ware J.E. The MOS
    SF-36 shot-form general health survey. Reliability and validity in patient popu lation / Med. Care. 1988. V. 26(7). P. 724 - 735.
  6. Jenial A., Tiwari R.C., Murray T. et al. Cancer statistics // CA Cancer J. Clin. 2004. V.54(l). P.8-29.
  7. Giyar G.H., Feeny D.K., Patrick D.L. Measuring health-related quality oflife // Ann. Intern. Med. 1993. V.8(8). P. 622 - 629.
  8. Bowling A. Measuring disease. A review of disease-specific quality of life measurement scales. Philadelphia:Open University Press. 1996.
  9. Tulsky D.S. An introduction to test the ory // Oncology. 1990. V.4(5). P 43 - 48.
  10. Patrick D.L., Deyo R.A. Generic and disease-specific measures in assessing health status and quality of life // Med. Care. 1989. V.27(3).
    P. 217 - 232.
  11. Aaronson N.K. Methodologic issues in assessing the quality of life of cancer patients // Cancer. 1991. V.67(3). P.844 - 850.
  12. Aaronson N.K., Cull A., Kaasa S. et al. The European Organisation for Research and Treatment of Cancer (EORTC) Modular Approach to Quality of Life Assessment in Oncology // Int. J. Ment. Health. 1994. V.23. P.75 - 96.
  13. Coast J., Peters T.J., Richards S.H. et al. Use of the EuroQOL among elderly acute care patients // Quality of Life Research. 1998. V.1. P.1 - 10.
  14. Detmar S.B., Aaronson N.K. Quality of life assessment in daily clinical oncology practice: a feasibility study // Eur. J. Cancer. 1998. V.34(8). P.1181 - 1186.
  15. Ganz P.A. Long-range effect of clinical trial interventions on quality of life // Cancer. 1994. V.74(9). P.2620-2624.
  16. Kaasa S. Using quality of life assessment methods in patients with advanced cancer: a clinical perspective // Eur. J. Cancer. 1995. V.6. P.15 - 17.
  17. Zietman A., Sacco D., Skowronski U. et al. Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors // J. Urol. 2003. V.170. P.1772 - 1776.
  18. Miyanaga N., Akaza H., Okumura T.et al. A bladder preservation regimen using intra-arterial chemotherapy and radiotherapy for invasive bladder cancer: a prospective study // Int. J. Urol. 2000. V.7. P. 41 - 48.
  19. Wei J.T., Dunn R.L., Sandler H.M. et al. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer / J. Clin. Oncol. 2002. V.20.
    P. 557-566.
  20. Talcott J.A., Clark J.A., Stark P.C. et al. Long-term treatment related complications of brachytherapy for early prostate cancer: a survey of patients previously treated // J. Urol. 2001. V.166. P.494 - 499.
  21. Henningsohn L., Wijkstrom H., Dickman P.W. et al. Distressful symptoms after radical radiotherapy for urinary bladder cancer // Radiother Oncol. 2002. V.62. P.215 - 225.
  22. Spry N., Halkett G., Aoun S. Development of a european organization for research and treatment of cancer module to assess the quality of life of patients with proctitis after pelvic radiotherapy for malignancy // Int. J. Radiation Oncology Biol. Phys. 2008. V.72(2). P.522 - 528.
  23. Lee C.T., David M. LatiniUrinary diversion: evidence-based outcomes assessment and integration into patient decision-making // BJUInternational.2008. V.102. P.1326 - 1333.
  24. Kikuchi E., Horiguchi Y., Nakashima J. Assessment of Long-Term Quality of Life Using the FACT-BL Questionnaire in Patients with an Ileal Conduit, Continent Reservoir, or Orthotopic Neobladder // Jpn. J. Clin. Oncol. 2006. V.36(11). P. 712 - 716.
  25. Velikovaa G., Weisb J., Hjermstadc M. et al. The EORTC QLQ-HDC29: A supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation // European journal of cancer. 2007. V.43. P. 87-94